SubsidieMeestersDevelopment and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI
Implicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools.
Projectdetails
Introduction
Heart failure is a serious chronic medical condition that impairs the heart’s ability to effectively pump blood. Globally, it has a prevalence of 64 million people.
Hospitalisation and Prevention
Heart failure patients often have to be hospitalised to manage symptoms exacerbation. These hospitalisations are preventable with data-based insights and tailored therapies. However, no holistic data platform for heart failure patients exists today.
Implicity's Solution
Implicity is set to change this situation with its suite of data-driven insights for managing heart failure. Implicity already provides a heart failure remote monitoring platform with symptoms-based decompensation detection features.
Project Development
In this project, we are developing a second module that focuses on:
- AI-based prediction of heart failure events based on cardiac implantable electronic devices’ data
- An end-to-end software suite managing alerts
- Treatments
- Patient engagement
- Workflow optimisation
This comprehensive approach aims to enable better care and decrease the hospitalisation burden.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.488.359 |
| Totale projectbegroting | € 2.488.359 |
Tijdlijn
| Startdatum | 1-5-2025 |
| Einddatum | 30-4-2027 |
| Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- IMPLICITYpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Advanced Remote Continuous patient Health mANaGemEnt SoLutionCheckpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients. | EIC Accelerator | € 2.436.000 | 2023 | Details |
Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoringThe Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations. | EIC Accelerator | € 2.299.633 | 2023 | Details |
The first heart failure therapy management point-of-care device with multiplex and multimodal sensorCardioCap is a handheld POC device that uses a finger-prick blood sample to simultaneously assess heart failure severity through four biomarkers, aiming to reduce re-hospitalization and mortality rates by 30%. | EIC Accelerator | € 2.499.999 | 2025 | Details |
Revolutionizing remote care of chronic disease patients – an interoperable and smart monitoring platformThe HumanITcare platform is an AI-driven solution that integrates data from various medical devices into EHRs, reducing patient visits by 40% and enhancing chronic disease management in Europe. | EIC Accelerator | € 2.438.800 | 2022 | Details |
Confident®, the digital simulation platform that revolutionizes cardiovascular interventionsConfident is an AI-driven platform that creates 3D virtual models for cardiovascular interventions, enabling personalized treatment planning to improve patient outcomes and reduce surgical risks. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Advanced Remote Continuous patient Health mANaGemEnt SoLution
Checkpointcardio aims to revolutionize patient monitoring by establishing a 24/7 remote observation center using AI and wearables to enhance care for critically ill and chronic disease patients.
Acorai Heart Monitor - Non-invasive multi-sensor device for heart failure monitoring
The Acorai Heart Monitor is a non-invasive device using machine learning to estimate cardiac pressure in heart failure patients, aiming to improve treatment outcomes and reduce hospitalizations.
The first heart failure therapy management point-of-care device with multiplex and multimodal sensor
CardioCap is a handheld POC device that uses a finger-prick blood sample to simultaneously assess heart failure severity through four biomarkers, aiming to reduce re-hospitalization and mortality rates by 30%.
Revolutionizing remote care of chronic disease patients – an interoperable and smart monitoring platform
The HumanITcare platform is an AI-driven solution that integrates data from various medical devices into EHRs, reducing patient visits by 40% and enhancing chronic disease management in Europe.
Confident®, the digital simulation platform that revolutionizes cardiovascular interventions
Confident is an AI-driven platform that creates 3D virtual models for cardiovascular interventions, enabling personalized treatment planning to improve patient outcomes and reduce surgical risks.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
HeartGuard: Thuismonitoring van patiënt met hartfalen halveert aantal ziekenhuisopnamenDit project ontwikkelt een thuismonitoringsysteem voor hartfalenpatiënten dat met AI-gestuurde data-analyse ziekenhuisopnames met 44% kan verminderen en de zorg efficiënt verbetert. | Mkb-innovati... | € 332.500 | 2023 | Details |
HeartGuard: Thuismonitoring van patiënt met hartfalen halveert aantal ziekenhuisopnamenHeartGuard ontwikkelt een thuismonitoringsysteem voor hartfalen, wat ziekenhuisopnames met 44% kan verminderen. | Mkb-innovati... | € 332.500 | 2023 | Details |
Boost of DiureticsHet project ontwikkelt een goedkope en effectieve methode voor thuismonitoring van hart- en longfalen, gericht op het tijdig signaleren van verslechtering om zorglasten te verlichten. | Mkb-innovati... | € 20.000 | 2020 | Details |
Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluationThis project aims to enhance myocardial infarction risk prediction by integrating data from wearable devices, biomarkers, and AI to identify novel risk factors for improved clinical decision-making. | ERC Starting... | € 1.405.894 | 2024 | Details |
Novel microsensing platform for remote patient monitoringThe FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users. | EIC Transition | € 2.499.051 | 2023 | Details |
HeartGuard: Thuismonitoring van patiënt met hartfalen halveert aantal ziekenhuisopnamen
Dit project ontwikkelt een thuismonitoringsysteem voor hartfalenpatiënten dat met AI-gestuurde data-analyse ziekenhuisopnames met 44% kan verminderen en de zorg efficiënt verbetert.
HeartGuard: Thuismonitoring van patiënt met hartfalen halveert aantal ziekenhuisopnamen
HeartGuard ontwikkelt een thuismonitoringsysteem voor hartfalen, wat ziekenhuisopnames met 44% kan verminderen.
Boost of Diuretics
Het project ontwikkelt een goedkope en effectieve methode voor thuismonitoring van hart- en longfalen, gericht op het tijdig signaleren van verslechtering om zorglasten te verlichten.
Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluation
This project aims to enhance myocardial infarction risk prediction by integrating data from wearable devices, biomarkers, and AI to identify novel risk factors for improved clinical decision-making.
Novel microsensing platform for remote patient monitoring
The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.